The Impact of the Use of the MAURISSE Application in People Suffering From an Addiction. (ALMA)
Substance Related Disorder, Personality Disorders
About this trial
This is an interventional supportive care trial for Substance Related Disorder focused on measuring eHealth, mHealth, application, substance use disorders, personality disorders, care observance, therapeutic alliance
Eligibility Criteria
Inclusion Criteria: Patient over 18 years old, Starting specialized treatment for addiction (addiction to substance and behavioral addiction too as money games addiction). Suffering from any type of addiction, with an active addiction requiring weekly monitoring of substance use. possessing a smartphone or having access to a smartphone and having access to an internet connection. Able to read and understand French. Affiliated or beneficiary of a social security scheme. Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research). Exclusion Criteria: Patient with cognitive or psychiatric disorders that may affect their ability to consent. Participation in another protocol involving a modification of the treatment for addiction. Known or suspected pregnancy. Person under legal protection.
Sites / Locations
- University Hospital of ToulouseRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Application group
Standard-of-care group
Patients randomized to the digital application arm will benefit from treatment as usual and will have access to the MAURISSE application, allowing them to communicate with the healthcare team using a messaging system, to report and follow substance use, to access a To-do list, to access personal multimedia contents helping with the treatment, to report a feeling of boredom (these moments presenting a risk of relapse) and finally to access a list of propositions in order to fight this feeling
These patients will benefit from the usual care within the center (appointments with doctors; regular follow-up meetings with nurses, psychologists, social workers, therapeutic groups depending on the evaluation).